Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.

PHASE2

Phase

TERMINATED

Status

Enrollment

OTHER_GOV

Sponsor class

Stopped Combination slow recruitment, short shelf life for placebo and insufficient funding for further drug production (probably anyway sufficient number included).

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: Mometasone furoate
DRUG: Placebo

Sponsor

Mogens Bove

Collaborators

[object Object]